Intel

Inside This Article: Wagner SprayTech has recalled more than 700,000 power steamers after receiving at least 156 reports of overheating and hot water release, including more than 50 burn injuries. The recall comes just weeks after another large-scale steam cleaner recall by Dupray, whose product was linked to 15 reports of boiler ruptures and four injuries. Consumer bodily injury claims can…

Misleading marketing materials, website content and social media posts can quickly become a significant Healthcare Liability exposure. In this short clip from our recent webinar on regenerative and alternative therapies, Lily Chetosky, Broker, Professional Liability, Burns & Wilcox, Chicago, Illinois, explains how patient expectations shaped by marketing can lead to costly claims. https://vimeo.com/1177367526/0dad2278f1?share=copy&fl=sv&fe=ci  

Inadequate patient screening in Telehealth can create significant Healthcare Liability exposure. In this short clip from our recent webinar on regenerative and alternative therapies, Kelli Bernstein, Inside Broker, Brokerage Division, Burns & Wilcox, Atlanta, Georgia, explains how gaps in screening and evaluation can lead to increased risk and potential claims. https://vimeo.com/1177366805/c08e5cfc77?share=copy&fl=sv&fe=ci  

Understanding the distinction between product and provider exposure is critical in Healthcare Liability. In this short clip from our recent webinar on regenerative and alternative therapies, special guest Carrie Roberts, RPLU, Vice President, Professional Brokerage Division, GenStar Insurance Services, explains how these differences influence risk evaluation and coverage. https://vimeo.com/1177361685/71abe58095?fl=ip&fe=ec  

Regenerative and alternative therapies—such as peptides, NAD+, ketamine, and stem cells—are rapidly expanding across healthcare and medspa settings. While these treatments present new opportunities for providers, they also introduce complex Healthcare Liability exposures. Now available on demand, this webinar features experts from Burns & Wilcox and GenStar Insurance Services as they explore evolving standards of care, regulatory scrutiny, and coverage…

Inside This Article: A recent Stanford and Harvard study found that medical AI systems generated severe clinical errors in a significant percentage of patient cases. Many healthcare professionals are using AI tools on the job, with one recent survey finding that almost half of nurses use generative AI at work. These reports point to an evolving risk landscape for…

Inside This Article: Federal regulators are claiming that former Lottery.com Inc. executives misled investors by falsely inflating revenues, according to reports. The Securities and Exchange Commission lawsuit follows guilty pleas by two former executives reportedly involved in a fraudulent $30 million financing deal, Bloomberg Law reported. Directors & Officers (D&O) Insurance can respond to these types of allegations, though coverage may depend on…

Evolving cyber risk, emerging A.I. exposures, and increased claim severity are shaping Professional Liability for 2026. See how rising cyber losses, shifting underwriting approaches, and the E&S market’s role in addressing complex risks are influencing coverage and pricing in the Professional Liability 2026 Forecast SlideShare.

Moderating rates, expanding capacity, and disciplined underwriting are setting the 2026 tone for Property & Casualty Insurance. See what is shaping the year ahead in our P&C 2026 Forecast SlideShare.  

Key Takeaways The E&S P&C market is in a strong position, supported by disciplined underwriting and strong carrier appetite. The E&S marketplace has recorded 14 consecutive years of premium growth, with Casualty lines representing the majority of direct premiums written. Social inflation, nuclear verdicts, and litigation funding continue to influence underwriting and pricing decisions, while tort reform in select states is beginning to…

Inside This Article: Alabama’s attorney general filed a lawsuit alleging that a medical spa administered non-FDA-approved versions of GLP-1 weight loss drugs without informing patients that the formulations were not authorized. The situation underscores growing concerns as medspas rapidly expand weight loss offerings amid strong consumer demand and uneven regulatory oversight. Allegations involving drug misrepresentation or lack of informed consent can…

In this Eye on 2026 P&C webinar clip, Andy Wood, Senior Vice President, Professional Liability Insurance, Burns & Wilcox, breaks down why Professional Liability remains fiercely competitive, how rising cyber and severity trends are pressuring profitability, and why 2026 may mark a shift toward stronger underwriting and pricing discipline. https://vimeo.com/1152987046/b5607e7a34?fl=ip&fe=ec